文献速递心律失常心力衰竭与心肌病

致心律失常性心肌病先证者与家族成员的外显率及疾病进展相似

High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy.
PubMed 文献 · Eur Heart J · 2020-01-01

该纵向队列研究纳入144例致心律失常性心肌病(AC)患者及突变阳性家族成员,评估结构进展及其对心律失常结局的影响。结果显示入组时58%家族成员已符合AC诊断标准,随访期间未患病家族成员年新外显率为8%;先证者与家族成员的结构进展速率相似,结构进展与严重室性心律失常事件风险显著升高相关(HR 21.24)。

要点

  • 家族成员在基因诊断时AC外显率已达58%,随访中年新外显率为8%。
  • 先证者与家族成员的结构进展速率相似,右室流出道直径年进展约0.5–0.6 mm。
  • 结构进展与严重室性心律失常事件风险显著升高相关(HR 21.24)。

核心结论

  • 超过半数家族成员在基因诊断时已符合AC标准,年外显率为8%。
  • 先证者与家族成员的结构进展速率相似,结构进展与严重室性心律失常事件风险升高相关。

研究设计与样本

  • 纵向队列研究,纳入144例AC患者及家族成员(48%女性,47%先证者,年龄40±16岁)。
  • 结构进展定义为从入组至随访出现新的Task Force影像学标准,进展速率定义为影像参数的年变化。
  • 随访时间7.0年(IQR 4.5–9.4),基于598次超声心动图检查分析。

主要发现

  • 入组时58%的家族成员已符合AC诊断标准。
  • 随访期间47%的入组时无AC的家族成员出现AC标准,年新外显率为8%。
  • 先证者与家族成员右室流出道直径年进展速率相似(0.5 mm/年 vs 0.6 mm/年,P=0.28)。
  • 家族成员右室面积变化分数年进展速率更高(-0.6%/年 vs -0.8%/年,P<0.01)。
  • 入组时无明确结构病变或心律失常史的86例患者中,8例(9%)发生首次严重室性心律失常事件,其中7例(88%)伴结构进展;结构进展与严重室性心律失常事件风险升高相关(HR 21.24,95%CI 2.47–182.81,P<0.01,校正年龄、性别及先证者状态)。

关键数值与推荐

  • 结构进展定义为从入组至随访出现新的Task Force影像学标准。
  • 进展速率定义为影像参数的年变化。

临床怎么用

  • 对突变阳性家族成员应定期进行影像学筛查以评估AC外显及结构进展。
  • 结构进展可提示严重室性心律失常事件风险升高,需加强心律失常监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: We aimed to assess structural progression in arrhythmogenic cardiomyopathy (AC) patients and mutation-positive family members and its impact on arrhythmic outcome in a longitudinal cohort study. METHODS AND RESULTS: Structural progression was defined as the development of new Task Force imaging criteria from inclusion to follow-up and progression rates as annual changes in imaging parameters. We included 144 AC patients and family members (48% female, 47% probands, 40 ± 16 years old). At genetic diagnosis and inclusion, 58% of family members had penetrant AC disease. During 7.0 [inter-quartile range (IQR) 4.5-9.4] years of follow-up, 47% of family members without AC at inclusion developed AC criteria, resulting in a yearly new AC penetrance of 8%. Probands and family members had a similar progression rate of right ventricular outflow tract diameter (0.5 mm/year vs. 0.6 mm/year, P = 0.28) by mixed model analysis of 598 echocardiographic examinations. Right ventricular fractional area change progression rate was even higher in family members (-0.6%/year vs. -0.8%/year, P < 0.01). Among 86 patients without overt structural disease or arrhythmic history at inclusion, a first severe ventricular arrhythmic event occurred in 8 (9%), of which 7 (88%) had concomitant structural progression. Structural progression was associated with higher incidence of severe ventricular arrhythmic events adjusted for age, sex, and proband status (HR 21.24, 95% CI 2.47-182.81, P < 0.01). CONCLUSION: More than half of family members had AC criteria at genetic diagnosis and yearly AC penetrance was 8%. Structural progression was similar in probands and family members and was associated with higher incidence of severe ventricular arrhythmic events.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Chivulescu M, Lie ØH, Popescu BA, et al. High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy. Eur Heart J. 2020. PMID: 31504415. doi:10.1093/eurheartj/ehz570

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。